Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-21

FDA Approved: TRULICITY — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

FDA approved a supplemental application for Trulicity (dulaglutide) submitted by Eli Lilly. The approval reflects a change to the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRULICITY (DULAGLUTIDE)

Snippet

SUPPL AP for TRULICITY (DULAGLUTIDE)